Clinical Scorecard: The Promise of Home Monitoring

At a Glance

Key Highlights

• Home monitoring with devices like ForeseeHome PHP improves early detection and visual acuity outcomes in AMD patients compared to standard monitoring.
• FDA-approved home OCT devices (e.g., SCANLY Home OCT) quantitatively track retinal fluid changes, alerting physicians to disease progression remotely.
• Outsourcing patient education, device support, and adherence monitoring to external RPM providers reduces clinic burden and improves patient compliance.

Guideline-Based Recommendations

Diagnosis

• Use home-based functional testing (PHP) and home OCT for early detection and monitoring of AMD progression.

Management

• Align treatment timing with disease progression detected via home monitoring rather than fixed clinic schedules.
• Leverage partnerships with RPM service providers for patient education, device training, and adherence support.

Monitoring & Follow-up

• Respond promptly to monitoring alerts generated by home OCT and PHP devices.
• Perform professional data review and interpretation every 30 days for patients enrolled in home monitoring programs.

Risks

• Potential impact on clinic workflow and revenue streams due to changes in patient visit frequency and in-office imaging utilization.
• Need to ensure patient adherence to home monitoring protocols to maintain effectiveness.

Patient & Prescribing Data

Intermediate AMD and NVAMD patients requiring frequent monitoring and treatment

Home monitoring leads to better visual acuity at conversion to wet AMD, reduces visit frequency by nearly 48% in NVAMD, and may improve patient retention by enabling safer extension of treatment intervals.

Clinical Best Practices

• Form close partnerships with external RPM providers to manage device logistics, patient education, and adherence monitoring.
• Bill professional services for data review and interpretation separately from in-office encounters to create recurring revenue streams.
• Use home monitoring to safely extend intervals between clinic visits, optimizing clinic capacity and accommodating more patients.
• Monitor patient adherence closely to maximize the benefits of home-based surveillance.

References

• Medicare RPM Spending Data
• HOME Study on ForeseeHome PHP in AMD
• Real-world Study on Home Monitoring Adherence
• FDA Approval of SCANLY Home OCT
• Home OCT Quantitative Monitoring
• Study on Home OCT Reducing Visit Frequency in NVAMD
• NVAMD Patient Attrition Study